• Je něco špatně v tomto záznamu ?

Preparation and advanced characterization of highly drug-loaded, 3D printed orodispersible tablets containing fluconazole

J. Pyteraf, W. Jamróz, M. Kurek, U. Bąk, J. Loskot, D. Kramarczyk, M. Paluch, R. Jachowicz

. 2023 ; 630 (-) : 122444. [pub] 20221128

Jazyk angličtina Země Nizozemsko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc22031996

Due to the possibility of designing various spatial structures, three-dimensional printing can be implemented in the production of customized medicines. Nevertheless, the use of these methods for the production of dosage forms requires further optimization, understanding, and development of printouts' quality verification mechanisms. Therefore, the goal of our work was the preparation and advanced characterization of 3D printed orodispersible tablets (ODTs) containing fluconazole, printed by the fused deposition modeling (FDM) method. We prepared and analyzed 7 printable filaments containing from 10% to 70% fluconazole, used as model API. Obtaining a FDM-printable filament with such a high API content makes our work unique. In addition, we confirmed the 12-month stability of the formulation, which, to our knowledge, is the first study of this type. Next, we printed 10 series of porous tablets containing 50 mg of API from both fresh and stored filaments containing 20 %, 40 %, or 70 % fluconazole. We confirmed the high quality and precision of the printouts using scanning electron microscopy. The detailed analysis of the tablets' disintegration process included the Pharmacopeial test, but also the surface dissolution imaging analysis (SDI) and the test simulating oral conditions performed in own-constructed apparatus. For each composition, we obtained tablets disintegrating in less than 3 min, i.e., meeting the criteria for ODTs required by the European Pharmacopeia. The filaments' storage at ambient conditions did not affect the quality of the tablets. All printed tablets released over 95% of the fluconazole within 30 min. Moreover, the printouts were stable for two weeks.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22031996
003      
CZ-PrNML
005      
20230131151507.0
007      
ta
008      
230120s2023 ne f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.ijpharm.2022.122444 $2 doi
035    __
$a (PubMed)36503848
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ne
100    1_
$a Pyteraf, Jolanta $u Department of Pharmaceutical Technology and Biopharmaceutics, Jagiellonian University Medical College, Medyczna 9, 30-688 Krakow, Poland. Electronic address: jolanta.pyteraf@uj.edu.pl
245    10
$a Preparation and advanced characterization of highly drug-loaded, 3D printed orodispersible tablets containing fluconazole / $c J. Pyteraf, W. Jamróz, M. Kurek, U. Bąk, J. Loskot, D. Kramarczyk, M. Paluch, R. Jachowicz
520    9_
$a Due to the possibility of designing various spatial structures, three-dimensional printing can be implemented in the production of customized medicines. Nevertheless, the use of these methods for the production of dosage forms requires further optimization, understanding, and development of printouts' quality verification mechanisms. Therefore, the goal of our work was the preparation and advanced characterization of 3D printed orodispersible tablets (ODTs) containing fluconazole, printed by the fused deposition modeling (FDM) method. We prepared and analyzed 7 printable filaments containing from 10% to 70% fluconazole, used as model API. Obtaining a FDM-printable filament with such a high API content makes our work unique. In addition, we confirmed the 12-month stability of the formulation, which, to our knowledge, is the first study of this type. Next, we printed 10 series of porous tablets containing 50 mg of API from both fresh and stored filaments containing 20 %, 40 %, or 70 % fluconazole. We confirmed the high quality and precision of the printouts using scanning electron microscopy. The detailed analysis of the tablets' disintegration process included the Pharmacopeial test, but also the surface dissolution imaging analysis (SDI) and the test simulating oral conditions performed in own-constructed apparatus. For each composition, we obtained tablets disintegrating in less than 3 min, i.e., meeting the criteria for ODTs required by the European Pharmacopeia. The filaments' storage at ambient conditions did not affect the quality of the tablets. All printed tablets released over 95% of the fluconazole within 30 min. Moreover, the printouts were stable for two weeks.
650    12
$a flukonazol $7 D015725
650    _2
$a uvolňování léčiv $7 D065546
650    _2
$a tablety $x chemie $7 D013607
650    12
$a 3D tisk $7 D066330
650    _2
$a poréznost $7 D016062
650    _2
$a farmaceutická technologie $x metody $7 D013678
655    _2
$a časopisecké články $7 D016428
700    1_
$a Jamróz, Witold $u Department of Pharmaceutical Technology and Biopharmaceutics, Jagiellonian University Medical College, Medyczna 9, 30-688 Krakow, Poland. Electronic address: witold.jamroz@uj.edu.pl
700    1_
$a Kurek, Mateusz $u Department of Pharmaceutical Technology and Biopharmaceutics, Jagiellonian University Medical College, Medyczna 9, 30-688 Krakow, Poland
700    1_
$a Bąk, Urszula $u Department of Pharmaceutical Technology and Biopharmaceutics, Jagiellonian University Medical College, Medyczna 9, 30-688 Krakow, Poland. Electronic address: urszula.bak@student.uj.edu.pl
700    1_
$a Loskot, Jan $u Department of Physics, Faculty of Science, University of Hradec Králové, Rokitanského 62, 500 03 Hradec Králové, Czech Republic. Electronic address: jan.loskot@uhk.cz
700    1_
$a Kramarczyk, Daniel $u Faculty of Science and Technology, Institute of Physics, University of Silesia in Katowice, 75 Pułku Piechoty 1a, 41-500 Chorzów, Poland. Electronic address: daniel.kramarczyk@smcebi.edu.pl
700    1_
$a Paluch, Marian $u Faculty of Science and Technology, Institute of Physics, University of Silesia in Katowice, 75 Pułku Piechoty 1a, 41-500 Chorzów, Poland. Electronic address: marian.paluch@us.edu.pl
700    1_
$a Jachowicz, Renata $u Department of Pharmaceutical Technology and Biopharmaceutics, Jagiellonian University Medical College, Medyczna 9, 30-688 Krakow, Poland. Electronic address: renata.jachowicz@uj.edu.pl
773    0_
$w MED00002359 $t International journal of pharmaceutics $x 1873-3476 $g Roč. 630, č. - (2023), s. 122444
856    41
$u https://pubmed.ncbi.nlm.nih.gov/36503848 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20230120 $b ABA008
991    __
$a 20230131151503 $b ABA008
999    __
$a ok $b bmc $g 1891026 $s 1183331
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2023 $b 630 $c - $d 122444 $e 20221128 $i 1873-3476 $m International journal of pharmaceutics $n Int. j. pharm. $x MED00002359
LZP    __
$a Pubmed-20230120

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...